Medical devices covers diagnostic, therapeutic, surgical, monitoring and assistive equipment and the consumables and software around them - from imaging systems and in-vitro diagnostics to implants, surgical instruments and wearables. Markets are driven by aging populations, chronic-disease prevalence, reimbursement and a shift toward minimally invasive and connected care.
How Credence Research isolates regulatory pathway timing, reimbursement risk, and component sourcing exposure across medical devices.
| Coverage Universe | Regulatory pipeline, reimbursement, and manufacturing tracking across: Diagnostic Imaging Systems, In-Vitro Diagnostics, Surgical Instruments and Robotics, Implantable Devices, Patient Monitoring Systems, and Wearable and Connected Health Devices. |
| Target Decision-Makers | Chief Regulatory and Quality Officers, Heads of Reimbursement Strategy, Medical Device Corporate Development Directors, Healthcare Private Equity investment leads, and investment committees requiring independent asset due diligence. |
| Primary Value Proposition | Aggregated device market totals mask real regulatory and reimbursement timing risk. We measure the financial impact of FDA clearance pathway delays, hospital procurement cycle length, and component sourcing risk on realistic device commercialization timelines. |
| Geographic Corridors | United States FDA 510(k) and premarket approval pathways, European Union Medical Device Regulation compliance transition, Chinese and Indian domestic device manufacturing localization mandates, and Japanese and South Korean device reimbursement frameworks. |
| Forecast Horizon | Granular 5- to 8-year rolling forecast models (2026 to 2034) updated via primary regulatory clearance tracking and hospital purchasing group procurement cycles. |
| Research Methodology | Primary interviews across regulatory affairs directors, hospital procurement managers, and device component suppliers, combined with bottom-up bill-of-materials cost modeling rather than secondary press aggregation. |
Systematic tracking of regulatory timelines, reimbursement risk, and component sourcing across medical device categories.
| Vertical Sector | Primary Metric Tracked | Executive Buyer Strategic Focus | Credence Intelligence Deliverable |
|---|---|---|---|
| Diagnostic Imaging Systems | Installed base replacement cycle, AI-assisted diagnostic adoption | Point-of-care imaging miniaturization, AI diagnostic software integration | Replacement cycle models, AI adoption tracking |
| In-Vitro Diagnostics | Assay throughput costs, molecular diagnostic adoption rates | Point-of-care testing expansion, companion diagnostic development | Throughput cost models, adoption rate benchmarks |
| Surgical Instruments & Robotics | Robotic system placement rates, procedure volume per system | Minimally invasive procedure expansion, surgical robotics platform competition | Placement rate tracking, procedure volume models |
| Implantable Devices | Regulatory approval timeline, component material sourcing risk | Biocompatible material innovation, remote monitoring-enabled implants | Approval timeline tracking, sourcing risk scores |
| Patient Monitoring Systems | Hospital procurement cycle length, interoperability standard compliance | Remote patient monitoring expansion, predictive deterioration alerting | Procurement cycle models, compliance cost tracking |
| Wearable & Connected Health Devices | Consumer versus clinical-grade device cost differential, data platform integration cost | Clinical-grade wearable reimbursement pathways, chronic disease remote management | Cost differential models, integration cost benchmarks |
In-depth research modules and customized commercial advisory for medical device executives.
| Market | Base Size | Forecast | CAGR | Report |
|---|---|---|---|---|
| Drones for Petroleum Market Size, Growth, Share and Forecast 2032 | USD 193.54 million | USD 8,229.72 million | 59.8% | View → |
| NPHP5 Retinal Degeneration Treatment Market Size and Forecast 2032 | USD 25.7 million | USD 285.22 million | 35.10% | View → |
| Organ-on-Chip Market Size, Share and Growth Report 2032 | USD 154.8 Million | USD 1698.73 Million | 34.91% | View → |
| Neuromorphic Computing ASIC Market Size, Growth and Forecast 2032 | USD 246.04 million | USD 2,186.57 million | 31.40% | View → |
| AI in Operating Room Market Size, Growth and Forecast 2032 | USD 528.18 million | USD 4,359.16 million | 30.19% | View → |
| Vein Illuminator Market Size, Growth, Share and Forecast 2032 | USD 81.13 million | USD 643.29 million | 29.54% | View → |
| Invisible Orthodontics Market Size, Share and Forecast 2032 | USD 6,554.51 million | USD 45,480.41 million | 27.46% | View → |
| Vein Illumination Devices Market Size, Growth and Forecast 2032 | USD 152 million | USD 984.2 million | 26.3% | View → |
Explore the Generative AI In Software As A Medical Device (SaMD) market, valued at USD 1.4 billion in 2025, forecast to 2034 at 24.52% CAGR. In-depth insights and trends.
The Africa Patient Monitoring Devices Market size was valued at USD 2,046.71 MN in 2021 and reached USD 2,363.35 MN in 2025. It is anticipated to reach USD 3,080.20 MN by 2032, growing at a CAGR of 3.21% during the forecast period.
The Latin America Infusion Therapy Devices Market size was valued at USD 1,704.07 MN in 2021 and reached USD 2,257.37 MN in 2025. It is anticipated to reach USD 3,852.87 MN by 2032, growing at a CAGR of 6.67% during the forecast period.
The Middle East Medical Consumables Market size was valued at USD 14,903.54 MN in 2021 and reached USD 18,404.91 MN in 2025. It is anticipated to reach USD 26,880.48 MN by 2032, growing at a CAGR of 4.63% during the forecast period.
The Asia Pacific Smart Medical Devices Market size was valued at USD 7,333.22 MN in 2021 and reached USD 10,575.15 MN in 2025. It is anticipated to reach USD 21,368.79 MN by 2032, growing at a CAGR of 8.88% during the forecast period.
The Asia Pacific Wearable Medical Devices Market size was valued at USD 5,524.70 MN in 2021 and reached USD 7,512.65 MN in 2025. It is anticipated to reach USD 13,134.93 MN by 2032, growing at a CAGR of 6.93% during the forecast period.
The Africa Minimally Invasive Surgery Devices Market size was valued at USD 1,015.99 MN in 2021 and reached USD 1,183.45 MN in 2025. It is anticipated to reach USD 1,635.10 MN by 2032, growing at a CAGR of 4.05% during the forecast period.
Elastomeric Infusion Pumps market size was valued at USD 1,220 million in 2024 and is anticipated to reach USD 2,111.22 million by 2032, registering a CAGR of 7.1% during the forecast period.
The Europe Ophthalmic Devices Market size was valued at USD 5,541.12 MN in 2021 and reached USD 6,896.16 MN in 2025. It is anticipated to reach USD 10,448.45 MN by 2032, growing at a CAGR of 5.14% during the forecast period.
The Asia Pacific Dental Equipment Market size was valued at USD 3,361.43 MN in 2021 and reached USD 2,657.13 MN in 2025. It is anticipated to reach USD 3,763.78 MN by 2032, growing at a CAGR of 4.26% during the forecast period.
The Middle East In Vitro Diagnostics Market size was valued at USD 2,568.78 MN in 2021 and reached USD 3,194.98 MN in 2025. It is anticipated to reach USD 4,546.99 MN by 2032, growing at a CAGR of 4.22% during the forecast period.
The Asia Pacific Diagnostic Imaging Devices Market size was valued at USD 5,593.99 MN in 2021 and reached USD 7,143.26 MN in 2025. It is anticipated to reach USD 10,583.56 MN by 2032, growing at a CAGR of 4.71% during the forecast period.
Balloon Infusers Market size was valued USD 2364 million in 2024 and is anticipated to reach USD 3575.3 million by 2032, at a CAGR of 5.31% during the forecast period.
The global Digital Therapeutic Devices Market size was estimated at USD 6,450.70 million in 2025 and is expected to reach USD 15,410.07 million by 2032, growing at a CAGR of 15.62% from 2025 to 2032.
The North America Cardiovascular Drugs Market size was valued at USD 35,146.60 MN in 2021 and reached USD 46,140.28 MN in 2025. It is anticipated to reach USD 70,300.43 MN by 2032, growing at a CAGR of 5.01% during the forecast period.
The North America Anticancer Drugs/Oncology Drugs Market size was valued at USD 64,394.03 MN in 2021 and reached USD 87,086.19 MN in 2025. It is anticipated to reach USD 150,370.53 MN by 2032, growing at a CAGR of 6.76% during the forecast period.
The DNA Forensics Market size was estimated at USD 6,940.47 million in 2025 and is expected to reach USD 11,601.47 million by 2032, growing at a CAGR of 8.94% from 2025 to 2032.
The global healthcare POS terminals market was valued at USD 16,218 million in 2024 and is projected to reach USD 35,840.49 million by 2032, expanding at a CAGR of 10.42% during the forecast period, according to Credence Research.
The global healthcare analytical testing market was valued at USD 8,183 million in 2024 and is projected to reach USD 18,870.73 million by 2032, expanding at a CAGR of 11.01% during the forecast period,
The Global Optogenetics market size was valued at USD 118 million in 2024 and is anticipated to reach USD 180.24 million by 2032.
The glycated albumin assay market was valued at USD 613 million in 2024 and is projected to reach USD 1,135.21 million by 2032, registering a CAGR of 8% during the forecast period.
The pregelatinized starch market reached USD 3,344.5 million in 2024 and is projected to reach USD 4,626.7 million by 2032, growing at a CAGR of 4.14% during the forecast period.
The global pregnancy detection kits market reached USD 1,694.5 million in 2024 and is projected to reach USD 2,541.95 million by 2032.
The Magnetic Resonance Imaging (MRI) market was valued at USD 7094.5 million in 2024 and is anticipated to reach USD 11566.13 million by 2032.
B2B clients served worldwide
Market research reports published
Of Fortune 1,000 companies as clients
Forecast horizon in every report
Get a free sample report or speak with a research analyst about your specific segment or region.